-transparent.png){kind=logo}
[Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia]. 1998
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
Russian Research Institute of Hematology and Transfusiology, St. Petersburg.
The content of nuclear high mobility group (HMG) proteins, activities of ornithine decarboxylase (ODC), adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) and also glycosaminoglycan (GAG) content and composition were studied in leukocytes of patients with chronic myelogenous leukemia in the phase of blast crisis (BC CML). Myeloid and lymphoid cytochemical variants of BC CML differ by biochemical parameters. It is suggested, that the content of HMG-proteins, activities of ODC and PNP, and electrophoretic patterns of GAGs could be used in diagnostics of two main variants of BC CML.
Related Publications
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
June 1973,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
October 1986,
Acta pathologica japonica,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
May 1978,
Southern medical journal,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
September 1993,
American journal of hematology,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
March 1981,
JAMA,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
September 1983,
Blood,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
January 1984,
Deutsche medizinische Wochenschrift (1946),
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
November 2012,
Blood,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
August 1987,
Cancer genetics and cytogenetics,
M F Kharchenko, and
L P Rybakova, and
L I Filanovskaia, and
L B Saltykova, and
E S Bitiukova, and
E G Shcherbakova, and
O A Rukavitsyn, and
S S Bessmel'tsev, and
K M Abdulkadyrov, and
M M Blinov
January 1985,
Acta haematologica,
